![Evolent Health's SWOT analysis: stock faces challenges amid growth potential](https://i-invdn-com.investing.com/news/World_News_9_150x108_S_1420026261.jpg)
Please try another search
Date | Price | Open | High | Low | Change % |
---|---|---|---|---|---|
Feb 17, 2025 | 105.426 | 105.426 | 105.426 | 105.426 | 0.00% |
Feb 14, 2025 | 105.425 | 105.425 | 105.425 | 105.425 | 0.17% |
Feb 13, 2025 | 105.247 | 105.247 | 105.247 | 105.247 | 0.13% |
Feb 12, 2025 | 105.113 | 105.113 | 105.113 | 105.113 | 0.34% |
Feb 11, 2025 | 104.759 | 104.759 | 104.759 | 104.759 | -0.06% |
Feb 10, 2025 | 104.818 | 104.818 | 104.818 | 104.818 | -0.12% |
Feb 07, 2025 | 104.940 | 104.940 | 104.940 | 104.940 | 0.18% |
Feb 06, 2025 | 104.748 | 104.748 | 104.748 | 104.748 | 0.36% |
Feb 05, 2025 | 104.368 | 104.368 | 104.368 | 104.368 | -0.11% |
Feb 04, 2025 | 104.481 | 104.481 | 104.481 | 104.481 | 0.31% |
Feb 03, 2025 | 104.154 | 104.154 | 104.154 | 104.154 | -0.08% |
Jan 31, 2025 | 104.241 | 104.241 | 104.241 | 104.241 | 0.28% |
Jan 30, 2025 | 103.947 | 103.947 | 103.947 | 103.947 | -0.08% |
Jan 29, 2025 | 104.029 | 104.029 | 104.029 | 104.029 | 0.45% |
Jan 28, 2025 | 103.566 | 103.566 | 103.566 | 103.566 | 0.47% |
Jan 27, 2025 | 103.079 | 103.079 | 103.079 | 103.079 | -0.15% |
Jan 24, 2025 | 103.239 | 103.239 | 103.239 | 103.239 | 0.01% |
Jan 23, 2025 | 103.226 | 103.226 | 103.226 | 103.226 | -0.12% |
Jan 22, 2025 | 103.355 | 103.355 | 103.355 | 103.355 | 0.10% |
Jan 21, 2025 | 103.250 | 103.250 | 103.250 | 103.250 | 0.03% |
Jan 20, 2025 | 103.216 | 103.216 | 103.216 | 103.216 | 0.29% |
Highest: 105.426 | Lowest: 103.079 | Difference: 2.347 | Average: 104.220 | Change %: 2.442 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review